A share price of Olema Pharmaceuticals Inc [OLMA] is currently trading at $28.79, up 2.53%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The OLMA shares have gain 14.70% over the last week, with a monthly amount drifted -6.16%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Olema Pharmaceuticals Inc [NASDAQ: OLMA] stock has seen the most recent analyst activity on January 07, 2026, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $40. Previously, Guggenheim started tracking the stock with Buy rating on October 08, 2025, and set its price target to $20. On August 12, 2025, Citigroup reiterated its Buy rating and revised its price target to $21 on the stock. Goldman started tracking the stock assigning a Buy rating and suggested a price target of $24 on April 02, 2024. Citigroup initiated its recommendation with a Buy and recommended $20 as its price target on January 30, 2024. Oppenheimer started tracking with an Outperform rating for this stock on July 21, 2023, and assigned it a price target of $21. In a note dated May 05, 2023, CapitalOne initiated an Overweight rating and provided a target price of $16 on this stock.
Olema Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $2.86 and $36.26. Currently, Wall Street analysts expect the stock to reach $42.71 within the next 12 months. Olema Pharmaceuticals Inc [NASDAQ: OLMA] shares were valued at $28.79 at the most recent close of the market. An investor can expect a potential return of 48.35% based on the average OLMA price forecast.
Analyzing the OLMA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.43, Equity is -0.42 and Total Capital is -0.53. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Olema Pharmaceuticals Inc [NASDAQ:OLMA] is 8.03. Also, the Quick Ratio is 8.03, while the Cash Ratio stands at 0.85.
Transactions by insiders
Recent insider trading involved Myles David C., Officer, that happened on Jan 12 ’26 when 10000.0 shares were purchased. Director, Harmon Cyrus completed a deal on Dec 22 ’25 to sell 2881.0 shares. Meanwhile, Director CLARK IAN T sold 0.26 million shares on Dec 19 ’25.
